Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-14
DOI
10.1038/s41467-021-23097-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
- (2020) A. Hochhaus et al. LEUKEMIA
- An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia
- (2020) Tun Kiat Ko et al. BLOOD
- Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
- (2020) Elsa Bernard et al. NATURE MEDICINE
- De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways
- (2019) Vera Magistroni et al. HAEMATOLOGICA
- Identification of novel pathogenic F13A1 mutation and novel NBEAL2 gene missense mutation in a pedigree with hereditary congenital factor XIII deficiency
- (2019) Siyuan Jia et al. GENE
- Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second generation tyrosine kinase inhibitors
- (2019) Georgios Nteliopoulos et al. HAEMATOLOGICA
- Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
- (2019) Susan Branford et al. LEUKEMIA
- Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high risk disease
- (2018) Susan Branford et al. BLOOD
- Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing
- (2018) Anna Stengel et al. LEUKEMIA
- Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia
- (2018) Thomas Ernst et al. LEUKEMIA
- Chronic myeloid leukemia with complex karyotypes: Prognosis and therapeutic approaches
- (2018) Ali Amin Asnafi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Functional genomic landscape of acute myeloid leukaemia
- (2018) Jeffrey W. Tyner et al. NATURE
- Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy
- (2017) TaeHyung Kim et al. LEUKEMIA RESEARCH
- Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
- (2017) R. Coleman Lindsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia
- (2017) E Togasaki et al. Blood Cancer Journal
- Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy
- (2016) TaeHyung Kim et al. BLOOD
- Somatic mosaicism in chronic myeloid leukemia in remission
- (2016) K. Mitani et al. BLOOD
- Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
- (2016) W. Wang et al. BLOOD
- Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation
- (2016) Matteo G. Della Porta et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
- (2016) Z Chen et al. LEUKEMIA
- Mutational landscape and clonal architecture in grade II and III gliomas
- (2015) Hiromichi Suzuki et al. NATURE GENETICS
- Integrated molecular analysis of adult T cell leukemia/lymphoma
- (2015) Keisuke Kataoka et al. NATURE GENETICS
- Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status
- (2014) M Schmidt et al. LEUKEMIA
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data
- (2013) Yuichi Shiraishi et al. NUCLEIC ACIDS RESEARCH
- ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia
- (2013) J Menezes et al. Blood Cancer Journal
- A robust model for read count data in exome sequencing experiments and implications for copy number variant calling
- (2012) Vincent Plagnol et al. BIOINFORMATICS
- How I treat CML blast crisis
- (2012) R. Hehlmann BLOOD
- Emerging kinetics of BCR–ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure
- (2012) Lee-Yung Shih et al. LEUKEMIA RESEARCH
- CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
- (2011) H. Makishima et al. BLOOD
- Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53
- (2011) Rashmi Kanagal-Shamanna et al. CANCER
- A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases
- (2011) V Grossmann et al. LEUKEMIA
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome
- (2011) Walter HA Kahr et al. NATURE GENETICS
- Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome
- (2011) Cornelis A Albers et al. NATURE GENETICS
- NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules
- (2011) Meral Gunay-Aygun et al. NATURE GENETICS
- SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations
- (2009) D. Nowak et al. BLOOD
- BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
- (2008) Charles G. Mullighan et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More